Zheng et al. conducted a study analyzing eight patients with stage C HCC, according to the Barcelona Clinic Liver Cancer classification, who were treated with anti-PD-1 antibodies without any concurrent antibiotic treatment [206]. Here, PDCD1 is linked to hepatocellular carcinoma.